Publications by authors named "Gary D Glick"

Claim this Profile
C
Correction to "Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor".
Dong-Ming Shen, Kate F Byth, Damien Bertheloot, Simona Braams, Sarah Bradley, Gary D Glick

J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor.
Dong-Ming Shen, Kate F Byth, Damien Bertheloot, Simona Braams, Sarah Bradley, Gary D Glick

J Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the NLRP3 inflammasome in inflammatory diseases.
Matthew S J Mangan, Edward J Olhava, William R Roush, H Martin Seidel, Gary D Glick

Nat Rev Drug Discov· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the NLRP3 inflammasome in inflammatory diseases.
Matthew S J Mangan, Edward J Olhava, William R Roush, H Martin Seidel, Gary D Glick

Nat Rev Drug Discov· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visualizing Mitochondrial FF-ATP Synthase as the Target of the Immunomodulatory Drug Bz-423.
Ilka Starke, Gary D Glick, Michael Börsch

Front Physiol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis.
Luigi Franchi, Ivan Monteleone, Ling-Yang Hao, Mark A Spahr, Wenpu Zhao, Gary D Glick

J Immunol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity.
Xiao Hu, Xikui Liu, Jacques Moisan, Yahong Wang, Charles A Lesch, Gary D Glick

Oncoimmunology· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease.
Jelle de Wit, M Hussein Al-Mossawi, Michael H Hühn, Carolina V Arancibia-Cárcamo, Karen Doig, Gary D Glick

J Allergy Clin Immunol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An automated phenotype-based microscopy screen to identify pro-longevity interventions acting through mitochondria in C. elegans.
Silvia Maglioni, Nayna Arsalan, Luigi Franchi, Alexander Hurd, Anthony W Opipari, Gary D Glick

Biochim Biophys Acta· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists.
Xiao Hu, Yahong Wang, Ling-Yang Hao, Xikui Liu, Chuck A Lesch, Gary D Glick

Nat Chem Biol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed death-1 controls T cell survival by regulating oxidative metabolism.
Victor Tkachev, Stefanie Goodell, Anthony W Opipari, Ling-Yang Hao, Luigi Franchi, Gary D Glick

J Immunol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-ATPase of Drosophila melanogaster forms 53-picosiemen (53-pS) channels responsible for mitochondrial Ca2+-induced Ca2+ release.
Sophia von Stockum, Valentina Giorgio, Elena Trevisan, Giovanna Lippe, Gary D Glick

J Biol Chem· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists.
Xiao Hu, Yahong Wang, Ling-Yang Hao, Xikui Liu, Chuck A Lesch, Gary D Glick

Nat Chem Biol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease.
Gary D Glick, Rodrigue Rossignol, Costas A Lyssiotis, Daniel Wahl, Charles Lesch

J Pharmacol Exp Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oligomycin-sensitivity conferring protein of mitochondrial ATP synthase: emerging new roles in mitochondrial pathophysiology.
Manuela Antoniel, Valentina Giorgio, Federico Fogolari, Gary D Glick, Paolo Bernardi

Int J Mol Sci· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effector T cells require fatty acid metabolism during murine graft-versus-host disease.
Craig A Byersdorfer, Victor Tkachev, Anthony W Opipari, Stefanie Goodell, Jacob Swanson, Gary D Glick

Blood· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dimers of mitochondrial ATP synthase form the permeability transition pore.
Valentina Giorgio, Sophia von Stockum, Manuela Antoniel, Astrid Fabbro, Federico Fogolari, Gary D Glick

Proc Natl Acad Sci U S A· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.
Daniel R Wahl, Craig A Byersdorfer, James L M Ferrara, Anthony W Opipari, Gary D Glick

Immunol Rev· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells.
Shan He, Koji Kato, Jiu Jiang, Daniel R Wahl, Shin Mineishi, Gary D Glick

PLoS One· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease.
Erin Gatza, Daniel R Wahl, Anthony W Opipari, Thomas B Sundberg, Pavan Reddy, Gary D Glick

Sci Transl Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NMR studies of an immunomodulatory benzodiazepine binding to its molecular target on the mitochondrial F(1)F(0)-ATPase.
Andrew C Stelzer, Richard W Frazee, Chad Van Huis, Joanne Cleary, Anthony W Opipari, Gary D Glick

Biopolymers· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptotic signaling activated by modulation of the F0F1-ATPase: implications for selective killing of autoimmune lymphocytes.
Thomas B Sundberg, Lara Swenson, Daniel R Wahl, Anthony W Opipari, Gary D Glick

J Pharmacol Exp Ther· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic basis for differential inhibition of the F1Fo-ATPase by aurovertin.
Kathryn M Johnson, Lara Swenson, Anthony W Opipari, Rolf Reuter, Nawid Zarrabi, Gary D Glick

Biopolymers· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bz-423 superoxide signals B cell apoptosis via Mcl-1, Bak, and Bax.
Neal B Blatt, Anthony E Boitano, Costas A Lyssiotis, Anthony W Opipari, Gary D Glick

Biochem Pharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
36 degrees step size of proton-driven c-ring rotation in FoF1-ATP synthase.
Monika G Düser, Nawid Zarrabi, Daniel J Cipriano, Stefan Ernst, Gary D Glick

EMBO J· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis